Denisa Wilkes 1/9/25 Denisa Wilkes 1/9/25

Safety and pharmacokinetics of single and multiple ascending doses of ALG-097558, a pan-coronavirus 3CL protease inhibitor, and relative bioavailability/food effect of a solid formulation…

Wataru Sugiura 1/9/25 Wataru Sugiura 1/9/25

COVID-19 Relapse and Viral Evolution in a Good Syndrome Patient: A Case Study

Nicholas C. Riola 1/9/25 Nicholas C. Riola 1/9/25

In vitro antiviral activity of obeldesivir and GS-441524 in combination with oral SARS-CoV-2 therapeutics nirmatrelvir/ritonavir or molnupiravir

Jeffery J Niesen 1/9/25 Jeffery J Niesen 1/9/25

Novel Ligand-Targeted Immunotherapy for the treatment of Human Respiratory Syncytial Virus

Conrrad Nicholls 1/9/25 Conrrad Nicholls 1/9/25

A Small Molecule Based Bispecific Antigenic Immunotherapy for the treatment of Dengue

Mahta Mortezavi 1/9/25 Mahta Mortezavi 1/9/25

Virologic Response and Safety After Oral Administration of PF-07817883, a Novel SARS-CoV-2 Mpro inhibitor, in Nonhospitalized Adults With Symptomatic COVID-19

David C. McGowan 1/9/25 David C. McGowan 1/9/25

Discovery and Preclinical Profile of ALG-097558, a SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Sonia Mathew 1/9/25 Sonia Mathew 1/9/25

Ocular Monkeypox Infection Leading to Vision Impairment in a 42-Year-Old Male with Well-Controlled HIV

Johan Lennerstrand 1/9/25 Johan Lennerstrand 1/9/25

Identification of inhibitors against the proteases of Dengue virus and other flaviviruses using a novel AI tool for drug discovery

William Colton 1/9/25 William Colton 1/9/25

Advancing Rapid Point-of-Care Diagnostics and Bacteriophage Therapeutics for Drug-Resistant Bacterial Infections

Samantha M.Y. Chen 1/9/25 Samantha M.Y. Chen 1/9/25

Novel Multiplex qRT-PCR Assay to Classify and Quantify Respiratory Syncytial Virus

Hannah N. Wilkins 1/9/25 Hannah N. Wilkins 1/9/25

The Blood Brain Barrier Demonstrates Capability to Influence Heterogenous Tenofovir and Emtricitabine Metabolism and Transport in the Brain

Namuli S 1/9/25 Namuli S 1/9/25

HIV associated factors among adult individuals during the treat all era at health centres in Uganda

Ndiana-Abasi Peter 1/9/25 Ndiana-Abasi Peter 1/9/25

Effect Of Polypharmacy On Medication Adherence In Geriatrics Persons Above 50 Years Living With Hiv In Southern Nigeria

Innocent H. Peter 1/9/25 Innocent H. Peter 1/9/25

Improving Cancer Care Outcomes for HIV-Positive Patients in Low- and Middle-Income Countries: A Systematic Review of Integrative Approaches.

Sana Musa 1/9/25 Sana Musa 1/9/25

HIV pre-exposure prophylaxis (PrEP) to improve access

M Murombo 1/9/25 M Murombo 1/9/25

‘Darling I’m looking out for my well being’: Unpacking the Stigma that Hinders Married African Women from Embracing PrEP for HIV Prevention

Lauren Middlebrooks 1/9/25 Lauren Middlebrooks 1/9/25

Human Immunodeficiency Virus Opt-out Testing Increases Syphilis Screening in Pediatric Emergency Departments

Alexxis Leyva 1/9/25 Alexxis Leyva 1/9/25

Using Natural Language Processing to Examine Stigmatizing Language in Electronic Health Care Records among Latinx Sexual Minorities

Irina Kolobova 1/9/25 Irina Kolobova 1/9/25

High real-world adherence with long-acting cabotegravir plus rilpivirine (CAB+RPV LA) among people with HIV (PWH) in the United States (US)